Biomarkers in Urothelial Cancer Patients Treated With Pembrolizumab
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)
- Status
- COMPLETED
- Phase
- PHASE3
Aldesleukin and Pembrolizumab in Treating Patients With Advanced or Metastatic Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE1
U3-1402 in Metastatic or Unresectable Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Multiple-dose Study of ASP8374, an Immune Checkpoint Inhibitor, as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetics (PK) and Safety of a Single Intravenous (IV) Dose of MK-3866 in Participants With Impaired Renal Function and in Healthy Controls (MK-3866-005)
- Status
- COMPLETED
- Phase
- PHASE1
Pembrolizumab + Idelalisib for Lung Cancer Study
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Vericiguat Drug-drug Interaction Study With Isosorbite Mononitrate in Stable Coronary Artery Disease Patients
- Status
- COMPLETED
- Phase
- PHASE1
Golimumab (MK-8259 / SCH900259) Treatment Withdrawal in Participants With Non-radiographic Axial Spondyloarthritis (GO-BACK) (MK-8259-038)
- Status
- COMPLETED
- Phase
- PHASE4
Pembrolizumab Plus Amurubicin in Patients With Refractory Small-cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Study of MK-2118 Administered as Intratumoral Injection as Monotherapy and in Combination With Pembrolizumab (MK-3475) or by Subcutaneous Injection in Combination With Pembrolizumab in the Treatment of Adults With Advanced/Metastatic Solid Tumors or Lymphomas (MK-2118-001)
- Status
- TERMINATED
- Phase
- PHASE1
Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair Defects
- Status
- COMPLETED
- Phase
- PHASE2
Antibiotic Prophlaxis for High-risk Laboring Women in Low Income Countries
- Status
- COMPLETED
- Phase
- PHASE4
Phase 2 Study of Imprime PGG & Pembrolizumab in Subjects With Adv SCCHN Who Failed Pembro Monotherapy or Experiencing SD
- Status
- TERMINATED
- Phase
- PHASE2
Dosing Obese With Noxafil® Under a Trial (DONUT)
- Status
- COMPLETED
- Phase
- PHASE4
Assessment of Multi-Level Interventions to Improve Adherence to Oral Medications in Cancer Patients
- Status
- RECRUITING
- Phase
- NA
Pembrolizumab in Combination With Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pembrolizumab Plus Chemotherapy in NSCLC With Targetable Genetic Alterations After Progression on Targeted Agents
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1